You are here

Ascension Via Christi using convalescent plasma to treat patients with severe COVID-19 infection

As of today, more than 60 patients at  Ascension Via Christi St. Francis have participated in a Mayo Clinic-led trial that uses plasma from patients who have recovered from COVID-19 to help others in their fight against the virus.
Half of those patients have been infused within the past three weeks.
Trial participants must be adult inpatients who either have severe or life-threatening COVID-19 disease or who are deemed by the treating physician to be at risk for progression to that stage of the disease.

The first patient was infused with convalescent plasma on May 13. 
"While the trial is still under way, the majority of the patients have improved sufficiently to be discharged from the hospital," said Janie Krull, director of Ascension Via Christi Research.
That's encouraging, says infectious disease specialist Maggie Hagan, MD, who serves as medical director of Infection Prevention and Control for Ascension Via Christi in Wichita.
"The armamentarium we now have to treat COVID infections, which includes convalescent plasma and antiviral medication, have made a big difference. We have seen patients improve quicker and avoid the need for a ventilator because of these therapies," says Dr. Hagan.
Ascension Via Christi Hospital in Manhattan began participating in the trial about the same time as the Wichita hospitals and Ascension Via Christi Hospital in Pittsburg began participating this week.
The convalescent plasma is provided at no cost to the recipient or provider by the American Red Cross. For information about how you can donate plasma, go to
About Roz Hutchinson

Roz Hutchinson is a Wichita wife, mother and chief spoiler of six grandkids and three Chihuahuas, a die-hard women's basketball fan, and director of Communications and Public Relations for Ascension Via Christi.